TWO SIGMA INVESTMENTS, LP
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1179392
NEW YORK, NY
Position in INDV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,801,565
+$7,444,187 QoQ
Shares Held
312,005
+77.5% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. INDV ranks #11 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,801,565 | 312,005 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,357,378 | 175,767 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||